Check our latest news and where we are going to be soon.
National Kidney Foundation (NKF) Innovation Fund invests in Biohope
We are proud to share that the National Kidney Foundation (NKF) Innovation Fund has invested in Biohope to advance personalized medicine in kidney transplantation. This investment will support further clinical validation and progress toward U.S. regulatory approval [...]
Biohope Welcomes Virginia González as New Chief Executive Officer
Biohope is glad to announce the appointment of Virginia González as its new Chief Executive Officer, marking an important milestone in the company’s evolution after more than ten years of growth and scientific consolidation. As CEO, Virginia [...]
Biohope Announces Collaboration to Advance Immunobiogram for Renal Transplant
Madrid, Spain, November 3rd, 2025 – Biohope, a Spanish company specialized in personalized medicine solutions for transplant and autoimmune patients, has signed a know-how agreement with Mayo Clinic, a global leader in medical research and patient [...]
Biohope Publishes New Pilot Study in Rheumatoid Arthritis, Opening the Path to a Novel Predictive Test
Biohope is proud to announce the publication of its latest scientific contribution in PLOS ONE: “Precision Medicine in Rheumatoid Arthritis: Evaluation of a New Approach to Predict Clinical Response to Methotrexate in Patients with Early Rheumatoid [...]
Biohope presents the results of the BIOTRAIM study at the WTC’25 and they are selected among the most relevant abstracts in kidney transplantation
Biohope participated in the World Transplant Congress (WTC 2025) in San Francisco from 3 to 6 August 2025. We presented two oral communications on the results of the BIOTRAIM study. The WTC 2025 was the most [...]
Biohope is pleased to welcome Andrea Espigares Correa, MD, as our new Clinical Science Director
Andrea brings broad clinical and research experience, with a strong foundation in internal medicine and a deep commitment to advancing patient-centered innovation. Her work spans various healthcare systems and therapeutic areas, contributing to a holistic understanding of [...]
Biohope Welcomes Joshua Lee as Medical Director for US
Biohope is delighted to announce the appointment of Joshua Lee, MD, as the Medical Director for US. He has a diverse background in medical affairs and product launch in Cardiovascular, Nephrology, and Transplant therapeutic areas. With 14 [...]
Biohope Receives an Honorary Plaque from the Spanish Association of Scientists in Recognition of Its Work in Developing Precision Medicine Diagnostic Tools
Biohope Receives an Honorary Plaque from the Spanish Association of Scientists in Recognition of Its Work in Developing Precision Medicine Diagnostic Tools Madrid, November 25th, 2024. The Spanish Association of Scientists held the XXVI Edition of the [...]
Spanish biotech Biohope develops a first in class device to personalize the first line of treatment for rheumatoid arthritis
The Community of Madrid grants the company, which received the Seal of Excellence of the European Innovation Council's Accelerator program, a grant of two million euros to carry out the project The economic burden of rheumatoid arthritis [...]
Biohope Secures Near-Maximum Funding in Madrid’s 2023 Call for Innovative SMEs
Madrid, September 2024 — Biohope, a pioneering biotech company, has been awarded €248,714.34 in funding under the 2023 call for support to innovative small and medium-sized enterprises (SMEs) by the Community of Madrid. This amount is just [...]
